title: A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
authors.affiliation: Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital and Regional Medical Center, University of Washington, Seattle, WA 98105, USA. david.suskind@seattlechildrens.org
authors.forename: David L
authors.initials: DL
authors.lastname: Suskind
authors.forename: Laura
authors.initials: L
authors.lastname: Finn
authors.forename: Ghassan
authors.initials: G
authors.lastname: Wahbeh
authors.forename: Dennis
authors.initials: D
authors.lastname: Christie
authors.forename: Simon
authors.initials: S
authors.lastname: Horslen
mesh_terms: D000015:Abnormalities, Multiple; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002648:Child; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D015209:Cholangitis, Sclerosing / Q000188:drug therapy*; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
chemical_list: D000924:Anticholesteremic Agents; D002756:Cholagogues and Choleretics; D002792:Cholestyramine Resin; D014580:Ursodeoxycholic Acid